Floatz logo

Therapeutic Asset Ratings

3,232 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Levonorgestrel
Polycystic Ovary Syndrome
Attikon HospitalP4BB (69)
Liraglutide
Inherited Lipid Metabolism Disorder
RenJi HospitalP4BB (69)
Liraglutide
Obesity Disorder
Ali AminianP4BB (69)
Loratadine
Fabry Disease
SanofiP4BB (69)
Lorazepam
Bipolar Disorder
Temple UniversityP4BB (69)
Lurasidone
Bipolar Disorder
George West Mental Health Foundation d/b/a Skyland TrailP4BB (69)
Lurasidone
Psychotic Disorder
George West Mental Health Foundation d/b/a Skyland TrailP4BB (69)
MANNITOL
Cystic Fibrosis
University of North Carolina, Chapel HillP4BB (69)
MELATONIN
Circadian Rhythm Sleep Disorder
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of HealthP4BB (69)
METHOTREXATE
Primary Mediastinal Large B-Cell Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (69)
METRONIDAZOLE
Colorectal Neoplasm
Helsinki University Central HospitalP4BB (69)
Mexidol
Ischemic Stroke
PharmasoftP4BB (69)
MIDAZOLAM
Anxiety Disorder
Theresa Jacob, PhD, MPHP4BB (69)
Mirabegron
Asthma
Kafrelsheikh UniversityP4BB (69)
Misoprostol
Dystocia
University of Texas at AustinP4BB (69)
Montelukast
Fabry Disease
SanofiP4BB (69)
Naltrexone
Obesity Disorder
Yale UniversityP4BB (69)
Naltrexone
Schizoaffective Disorder
Mayo ClinicP4BB (69)
Naproxen
Chronic Pain Syndrome
Endeavor HealthP4BB (69)
NEBIVOLOL
Hypertensive Disorder
Kafrelsheikh UniversityP4BB (69)
NEPENTHE
Morbid Obesity
Kirsehir Ahi Evran UniversitesiP4BB (69)
NEPENTHE
Substance-Related Disorder
Samsun UniversityP4BB (69)
NEPENTHE
Sickle Cell Disease
Oman Medical Speciality BoardP4BB (69)
Nicardipine
Malignant Hypertension
Haseki Training and Research HospitalP4BB (69)
Nivolumab
Lung Cancer
University of ChicagoP4BB (69)
Showing 1101 to 1125 of 3,232 assets
PreviousPage 45 of 130Next